NCT07401875 2026-04-02
A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
M.D. Anderson Cancer Center
Phase 1 Recruiting
M.D. Anderson Cancer Center
Arcus Biosciences, Inc.
Dana-Farber Cancer Institute
Bristol-Myers Squibb